The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...

In our news wrap Tuesday, the UN says no aid has reached Palestinians two days after Israel ended its three-month blockade, the FDA is changing the way it approves annual COVID-19 vaccines, the World ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...

Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...